(Q53305324)

13 May 2018

title

[Serous genital carcinoma: molecular pathogenesis and the role of tubal fimbria]. (English)

1 reference

13 May 2018

author name string

S Lax

series ordinal

1

1 reference

13 May 2018

language of work or name

German

0 references

publication date

1 December 2009

1 reference

13 May 2018

published in

Pathologe

1 reference

13 May 2018

volume

30 Suppl 2

1 reference

13 May 2018

page(s)

210-216

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1007/s00292-009-1215-3

exact match

0 references

cites work

Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature

1 reference

https://api.crossref.org/works/10.1007%2FS00292-009-1215-3

Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-009-1215-3

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-009-1215-3

Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-009-1215-3

Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-009-1215-3

Diverse tumorigenic pathways in ovarian serous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-009-1215-3

Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-009-1215-3

WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma

21 January 2018

1 reference

12 December 2020

Precursors to pelvic serous carcinoma and their clinical implications

1 reference

12 December 2020

Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma

1 reference

12 December 2020

Ovarian, peritoneal, and endometrial serous carcinoma: clonal origin of multifocal disease

1 reference

12 December 2020

Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications

1 reference

12 December 2020

Early de novo ovarian cancer and cancer developing in benign ovarian lesions

1 reference

12 December 2020

New insights into the pathogenesis of serous ovarian cancer and its clinical impact

1 reference

12 December 2020

Serous intraepithelial carcinoma arising in an endometrial polyp: a proposal for modification of terminology

1 reference

12 December 2020

The distal fallopian tube: a new model for pelvic serous carcinogenesis.

1 reference

12 December 2020

Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance

1 reference

12 December 2020

Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.

1 reference

12 December 2020

Mutational analysis of K-ras segregates ovarian serous carcinomas into two types: invasive MPSC (low-grade tumor) and conventional serous carcinoma (high-grade tumor).

1 reference

12 December 2020

Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers.

1 reference

12 December 2020

Early de novo ovarian carcinoma. A study of fourteen cases.

1 reference

12 December 2020

Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention

1 reference

12 December 2020

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

1 reference

12 December 2020

Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation

1 reference

12 December 2020

K-ras mutations in Müllerian inclusion cysts associated with serous borderline tumors of the ovary

1 reference

12 December 2020

Induction of a differentiated ciliated cell phenotype in primary cultures of Fallopian tube epithelium.

1 reference

12 December 2020

Risk factors for a serous cancer precursor ("p53 signature") in women with inherited BRCA mutations

1 reference

12 December 2020

p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis

1 reference

12 December 2020

Intercepting pelvic cancer in the distal fallopian tube: theories and realities

1 reference

12 December 2020

Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma

1 reference

12 December 2020

10.1007/S00292-009-1215-3

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018